Table 4. Univariate analysis for survivals.
| Parameters | 5-year PFS | P value b | 5-year OS | P value b |
|---|---|---|---|---|
| SUVmax a | 0.494 | 0.282 | ||
| Low | 73% | 90% | ||
| High | 57% | 72% | ||
| MTV a | <0.001 | <0.001 | ||
| Low | 88% | 98% | ||
| High | 37% | 60% | ||
| TLG a | <0.001 | <0.001 | ||
| Low | 83% | 92% | ||
| High | 34% | 67% | ||
| NCCN-IPI score | 0.039 | 0.036 | ||
| 0-3 | 76% | 92% | ||
| 4-8 | 51% | 71% | ||
| Ann Arbor stage | 0.02 | 0.046 | ||
| I/II | 82% | 94% | ||
| III/IV | 56% | 76% | ||
| B symptoms | <0.001 | 0.027 | ||
| No | 86% | 93% | ||
| Yes | 46% | 70% | ||
| LDH level | 0.013 | 0.015 | ||
| normal | 77% | 88% | ||
| elevated | 48% | 73% | ||
| Subtype | 0.761 | 0.762 | ||
| GCB | 74% | 88% | ||
| non-GCB | 65% | 80% |
Abbreviations: PFS, progression-free survival; OS, overall survival; SUVmax, maximum standard uptake value; MTV, metabolic tumor volume; TLG, total lesion glycolysis; NCCN-IPI, National Comprehensive Cancer Network-International Prognostic Index; LDH, lactate dehydrogenase; GCB, germinal centre B-cell.
a
SUVmax, MTV and TLG were dichotomized by cutoff values from ROC analysis.
b
Log-rank test.